Mediplasma collaborates with Research Institutes and with Productive Companies, developing synergies that allow to expand and complete the range of services and products offered.
• UNIBA (University of Bari)
Department of Chemistry: Theory and technique of cold plasmas; Instrumental chemical and chemical-physical analysis.
• UNIMOL (University of Molise)
Department of Health Sciences: (ask Prof. Costagliola).
• UNINA (University of Naples)
Department of Materials Engineering (insert new name): Biomaterials; Tissue engineering; (ask Prof. Gloria).
• CNR (National Research Council)
Institute for Polymers, Composites and Biomaterials: Instrumental, chemical and chemical-physical analysis.
National Agency for New Technologies, Energy and Sustainable Economic Development
• PLASMA SOLUTION s.r.l.,
spin-off of UNIBA: chemical plasmo processes for the industry; Design of chemical plastics reactors customized for industry and research
• MICROBIOPROBE s.r.l .
design, production and marketing of medical devices.
We have started, on behalf of Safilens, an experimentation for the study of immobilization reactions of polysaccharides on the surface of contact lenses, using plasmo-chemical technologies. This experimentation aims to optimize the treatment of contact lenses in order to increase the comfort of using these devices.
As on behalf of Safilens we are carrying out, on behalf of Soleko, an experimentation for the study of immobilization reactions of polysaccharides on the surface of contact lenses, using plasmo-chemical technologies.
We have begun, on behalf of MedLac, an experimentation for the plasma deposition of PEO-like coating on the surface of rigid contact lenses. This experimentation aims to optimize the treatment of contact lenses in order to increase the comfort of using these devices.
We are in talks with various leading companies in the sector, such as Medtronic, for the study of feasibility and subsequent prototyping on commercial substrates, of nanocomposite deposition processes with controlled drug release.
These nanocomposite coatings are deposited in cold plasmas at atmospheric pressure fed by a buffer gas (eg helium), by one or more monomers (eg ethylene), and by the aerosol of a solution (generally aqueous) of the drug.
• ALFA INTES
We are about to begin a new experimentation, on behalf of the company Alfa Intes, for the study of plasma surface modification treatments aimed at the deposition of PEO-like coating on the surface of ophthalmic stunts. This experimentation aims to optimize the treatment of ophthalmic stunts in order to increase the comfort of using these devices.
During a competition organized by the Maccaferri Group, we proposed a project with the aim of searching for original packaging solutions, studying and analyzing the properties of the materials and therefore improving their characteristics through our innovative cold plasmas surface treatment.
For example, depending on the food requirements, it is possible to modify the surface of hydrophobic or hydrophilic, oleophobic or oleophilic polymers, increasing or decreasing the cell adhesion to the material. Or again, it is possible to deposit via plasma coating hydrophilic nano-composites containing silver, resistant to bacterial contamination.
• TSEM s.p.a .
design and production of innovative technologies in the areas of Health, Energy and Safety, medical equipment, joint prostheses.